PTGS2 and breast cancer: These models have significantly advanced our knowledge of the central role played by of COX-2 and PGE2 in mammary tumor development, in resistance to apoptosis, as well as of the role of PGE2 in the “angiogenic switch” that activates development of new blood vessels, considered essential for tumor expansion and invasion [13], [14], [15].